Charles River Laboratories International, Inc.

CRL Healthcare Diagnostics & Research

Charles River Laboratories International, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $4.0 billion, down 0.85% from fiscal 2024. In the quarter to June 2026, revenue fell 2.72%, EPS fell 102.8%, free cash flow fell 12.2% and total debt rose 12.3%, each against the same quarter a year earlier. Member of the S&P 500; operating cash flow growth for three consecutive years; insiders bought in the last twelve months.

299.77 6.47 −2.11%
Market cap
$14.6B
P/E
0.0×
Fwd P/E
29.6×
Dividend yield
—
F-score
5/9
Altman Z
2.40
Beneish M
−3.11
Dividend safety
n/a
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
23.19 42.72 24.08 29.55 34.04 48.49 22.82 25.30 1,025.56 0.00
Piotroski F-Score
4 5 5 4 6 4 6 5 4 5
P/S ratio
2.14 2.83 2.39 2.84 4.23 5.35 2.79 2.91 2.34 2.46
Altman Z-Score
2.24 2.90 2.28 2.43 3.23 3.55 2.56 2.74 2.44 2.40
P/FCF ratio
13.75 22.30 18.02 21.87 32.58 35.62 37.63 32.84 18.91 19.07
Altman Z″-Score (non-manufacturers)
1.81 2.38 1.74 1.70 1.99 1.84 2.17 2.52 2.24 1.80
Beneish M-Score
(2.42) (2.60) (2.58) (2.58) (2.42) (2.64) (2.38) (2.54) (2.97) (3.11)
P/Operating CF
30.33 42.29 38.77 41.20 89.47 82.66 47.27 54.31 59.52 67.02
P/B ratio
4.29 5.02 4.11 4.55 5.84 7.46 3.72 3.33 2.74 3.12
EV/Sales
2.80 3.36 3.04 3.47 4.83 6.05 3.41 3.48 2.85 2.94
EV/EBITDA
12.95 14.87 13.99 16.56 21.17 25.03 14.21 15.43 14.34 19.90
EV/FCF
18.02 26.46 22.91 26.71 37.19 40.24 46.02 39.34 22.99 22.78
Current Ratio
1.53 1.78 1.61 1.44 1.43 1.23 1.32 1.52 1.41 1.29
Net Debt/EBITDA
3.07 2.34 2.99 3.00 2.62 2.83 2.59 2.55 2.54 3.24
Debt/Equity
1.47 1.09 1.26 1.15 0.93 1.05 0.91 0.73 0.65 0.67
ROE
19.63% 13.08% 19.13% 17.04% 19.40% 16.79% 17.62% 14.42% 0.29% (4.35%)
ROA
6.48% 4.37% 6.67% 5.90% 7.15% 6.25% 6.65% 6.01% 0.13% (1.97%)
ROIC
7.59% 8.88% 7.42% 6.67% 6.99% 7.43% 7.46% 6.46% 2.58% 0.31%
Return on Tangible Assets
15.74% 10.77% 17.79% 18.60% 24.52% 25.52% 26.82% 21.64% 0.51% (7.28%)
Average Days of Receivables
79.03 84.49 76.07 71.58 77.11 66.28 69.07 68.98 64.97 64.44
Earnings Yield
4.31% 2.34% 4.15% 3.38% 2.94% 2.06% 4.38% 3.95% 0.10% (1.48%)
Free Cash Flow Yield
7.27% 4.49% 5.55% 4.57% 3.07% 2.81% 2.66% 3.04% 5.29% 5.24%
Free Cash Flow per Share
5.56 4.96 6.28 6.99 7.67 10.58 5.80 7.13 9.76 10.46
Book value per Share
17.85 22.06 27.53 33.61 42.75 50.48 58.67 70.32 67.48 63.96
Free Cash Flow
261.61 235.64 301.09 340.42 380.02 532.03 294.91 365.37 501.61 518.49
EV/EBIT
19.85 21.63 20.82 25.90 32.66 36.29 20.85 23.28 50.73 469.42
Other line items

Show all line items

Columns are period end dates